BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 26267146)

  • 41. Inhibition of Hypoxia-Induced Retinal Angiogenesis by Specnuezhenide, an Effective Constituent of Ligustrum lucidum Ait., through Suppression of the HIF-1α/VEGF Signaling Pathway.
    Wu J; Ke X; Fu W; Gao X; Zhang H; Wang W; Ma N; Zhao M; Hao X; Zhang Z
    Molecules; 2016 Dec; 21(12):. PubMed ID: 28009852
    [TBL] [Abstract][Full Text] [Related]  

  • 42. JNK-NQO1 axis drives TAp73-mediated tumor suppression upon oxidative and proteasomal stress.
    Kostecka A; Sznarkowska A; Meller K; Acedo P; Shi Y; Mohammad Sakil HA; Kawiak A; Lion M; Królicka A; Wilhelm M; Inga A; Zawacka-Pankau J
    Cell Death Dis; 2014 Oct; 5(10):e1484. PubMed ID: 25341038
    [TBL] [Abstract][Full Text] [Related]  

  • 43. p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor.
    Testoni B; Schinzari V; Guerrieri F; Gerbal-Chaloin S; Blandino G; Levrero M
    Oncogene; 2011 Jun; 30(23):2670-8. PubMed ID: 21399658
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Up-regulation of hypoxia-inducible factors HIF-1alpha and HIF-2alpha under normoxic conditions in renal carcinoma cells by von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Haas R; Brauch H; Acker T; Flamme I; Plate KH
    Oncogene; 2000 Nov; 19(48):5435-43. PubMed ID: 11114720
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Celecoxib Down-Regulates the Hypoxia-Induced Expression of HIF-1α and VEGF Through the PI3K/AKT Pathway in Retinal Pigment Epithelial Cells.
    Sun YZ; Cai N; Liu NN
    Cell Physiol Biochem; 2017; 44(4):1640-1650. PubMed ID: 29216640
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The p53 family and VEGF regulation: "It's complicated".
    Farhang Ghahremani M; Goossens S; Haigh JJ
    Cell Cycle; 2013 May; 12(9):1331-2. PubMed ID: 23588071
    [No Abstract]   [Full Text] [Related]  

  • 47. Topotecan inhibits vascular endothelial growth factor production and angiogenic activity induced by hypoxia in human neuroblastoma by targeting hypoxia-inducible factor-1alpha and -2alpha.
    Puppo M; Battaglia F; Ottaviano C; Delfino S; Ribatti D; Varesio L; Bosco MC
    Mol Cancer Ther; 2008 Jul; 7(7):1974-84. PubMed ID: 18645007
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High-density lipoproteins augment hypoxia-induced angiogenesis via regulation of post-translational modulation of hypoxia-inducible factor 1α.
    Tan JT; Prosser HC; Vanags LZ; Monger SA; Ng MK; Bursill CA
    FASEB J; 2014 Jan; 28(1):206-17. PubMed ID: 24022405
    [TBL] [Abstract][Full Text] [Related]  

  • 49. miR-148a inhibits early relapsed colorectal cancers and the secretion of VEGF by indirectly targeting HIF-1α under non-hypoxia/hypoxia conditions.
    Tsai HL; Miao ZF; Chen YT; Huang CW; Yeh YS; Yang IP; Wang JY
    J Cell Mol Med; 2019 May; 23(5):3572-3582. PubMed ID: 30834693
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Involvement of N-terminally truncated variants of p73, deltaTAp73, in head and neck squamous cell cancer: a comparison with p53 mutations.
    Faridoni-Laurens L; Tourpin S; Alsafadi S; Barrois M; Temam S; Janot F; Koscielny S; Bosq J; Bénard J; Ahomadegbe JC
    Cell Cycle; 2008 Jun; 7(11):1587-96. PubMed ID: 18469517
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The DEK oncogene activates VEGF expression and promotes tumor angiogenesis and growth in HIF-1α-dependent and -independent manners.
    Zhang Y; Liu J; Wang S; Luo X; Li Y; Lv Z; Zhu J; Lin J; Ding L; Ye Q
    Oncotarget; 2016 Apr; 7(17):23740-56. PubMed ID: 26988756
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [TAp73α is Upregulated in the Most Common Human Cancers].
    Iscan E; Karakülah G; Ekin U; Ozturk M; Uzuner H; Suner A
    Mol Biol (Mosk); 2022; 56(2):320. PubMed ID: 35403622
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of novel VHL target genes and relationship to hypoxic response pathways.
    Maina EN; Morris MR; Zatyka M; Raval RR; Banks RE; Richards FM; Johnson CM; Maher ER
    Oncogene; 2005 Jun; 24(28):4549-58. PubMed ID: 15824735
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors.
    Mukhopadhyay D; Datta K
    Semin Cancer Biol; 2004 Apr; 14(2):123-30. PubMed ID: 15018896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p73 and IGF1R Regulate Emergence of Aggressive Cancer Stem-like Features via miR-885-5p Control.
    Meier C; Hardtstock P; Joost S; Alla V; Pützer BM
    Cancer Res; 2016 Jan; 76(2):197-205. PubMed ID: 26554827
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular and functional evaluation of a novel HIF inhibitor, benzopyranyl 1,2,3-triazole compound.
    Park K; Lee HE; Lee SH; Lee D; Lee T; Lee YM
    Oncotarget; 2017 Jan; 8(5):7801-7813. PubMed ID: 27999195
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The antiepidermal growth factor receptor monoclonal antibody cetuximab/C225 reduces hypoxia-inducible factor-1 alpha, leading to transcriptional inhibition of vascular endothelial growth factor expression.
    Luwor RB; Lu Y; Li X; Mendelsohn J; Fan Z
    Oncogene; 2005 Jun; 24(27):4433-41. PubMed ID: 15806152
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Topotecan blocks hypoxia-inducible factor-1alpha and vascular endothelial growth factor expression induced by insulin-like growth factor-I in neuroblastoma cells.
    Beppu K; Nakamura K; Linehan WM; Rapisarda A; Thiele CJ
    Cancer Res; 2005 Jun; 65(11):4775-81. PubMed ID: 15930297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TAp73 transcriptionally represses BNIP3 expression.
    Petrova V; Mancini M; Agostini M; Knight RA; Annicchiarico-Petruzzelli M; Barlev NA; Melino G; Amelio I
    Cell Cycle; 2015 Aug; 14(15):2484-93. PubMed ID: 25950386
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Sp1 binds to the external promoter of the p73 gene and induces the expression of TAp73gamma in lung cancer.
    Logotheti S; Michalopoulos I; Sideridou M; Daskalos A; Kossida S; Spandidos DA; Field JK; Vojtesek B; Liloglou T; Gorgoulis V; Zoumpourlis V
    FEBS J; 2010 Jul; 277(14):3014-27. PubMed ID: 20528922
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.